Business Finland, the government organization for innovation funding and trade, travel and investment promotion, has published a brochure on ‘Cancer Expertise from Finland’. The digital booklet showcases Finland as a global leader in cancer research
We are very happy that LS CancerDiag has been selected to be part of the first cohort of the X-Europe programme – HealthTech, MedTech and BioTech! LS CancerDiag is proud to have been selected from the
We are delighted to announce that LS CancerDiag has been selected as a participant to the EIT Health Bridghead Global programme! The Bridgehead programme provides European start-ups and scale-ups with individualised support in growing their
Back in January when we were living in a different world, our CBO Philippe Arnez talked with Logan Plaster at the StartUp Health Festival in San Francisco. You can watch the full interview below which
Lynch syndrome. Even though it is the most common hereditary cancer syndrome in the world, it is mostly unknown. Lynch syndrome prevalence is currently estimated at 1 in 279 globally[1], meaning that in Europe alone
We are living through truly unprecedented times. As a company we are taking all the necessary precautions to keep our employees safe, while continuing to serve our customers. However, we also want to take a
LS CancerDiag gets the patent granted in Brazil for its innovative DiagMMR® test. The largest country in Latin America completes the already impressive patent portfolio of LS CancerDiag. Brazil brings the total count to 29
Back in January, our CBO Philippe Arnez spent two days at the Startup Health Festival in San Francisco. LS CancerDiag is proud to be part of this dynamic and inspiring community. We are glad to
LS CancerDiag looks back on the year marked by the achievement of major milestones. 2019 started off with obtaining the CE mark for DiagMMR® as in vitro diagnostic medical device (IVD MD), enabling commercialization in
The last year of this decade has been a very successful one for LS CancerDiag, where many important milestones were achieved, and the basis was laid for strong growth over the coming years. To gear
Check out page 56/57 to find @lscancerdiag in this publication from @BusinessFinland! Finland is a global leader in cancer research and care and we are proud to be part of this ecosystem! #FinlandWorks #DiagMMR #LynchSyndrome #MissionCancer https://www.businessfinland.fi/en/whats-new/news/2020/get-to-know-cancer-expertise-from-finland/
European guidelines for #Lynchsyndrome by @EHTG_Tweets and @escp_tweets online (part). See the executive summary available @BJSurgery
Thank you @GabrielaMoslein @IonutNegoi @AndyLatchford @mev_dv @ProfEmmaCrosbie @neilajryan @CaPP3 @ASampaioSoares
https://bjssjournals.onlinelibrary.wiley.com/doi/full/10.1002/bjs.11902
